au.\*:("THIELE, Juergen")
Results 1 to 25 of 31
Selection :
Philadelphia Chromosome-Negative Chronic Myeloproliferative DiseaseTHIELE, Juergen.American journal of clinical pathology. 2009, Vol 132, Num 2, pp 261-280, issn 0002-9173, 20 p.Conference Paper
Clinical and pathological criteria for the diagnosis of essential thrombocythemia, Polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia)MICHIELS, Jan Jacques; THIELE, Juergen.International journal of hematology. 2002, Vol 76, Num 2, pp 133-145, issn 0925-5710, 13 p.Article
Bone marrow manifestation of lyme disease (Lyme Borreliosis)KVASNICKA, Hans M; THIELE, Juergen; AHMADI, Tahamtan et al.British journal of haematology. 2003, Vol 120, Num 5, issn 0007-1048, p. 723Article
The 2008 World Health Organization Classification System for Myeloproliferative Neoplasms: Order Out of ChaosTEFFERI, Ayalew; THIELE, Juergen; VARDIMAN, James W et al.Cancer. 2009, Vol 115, Num 17, pp 3842-3847, issn 0008-543X, 6 p.Article
Hematopathologic findings in chronic idiopathic myelofibrosisTHIELE, Juergen; KVASNICKA, Hans M.Seminars in oncology. 2005, Vol 32, Num 4, pp 380-394, issn 0093-7754, 15 p.Article
The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra veraKVASNICKA, Hans Michael; THIELE, Juergen.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 4, pp 362-371, issn 0094-6176, 10 p.Article
The value of bone marrow histology in differentiating between early stage polycythemia vera and secondary (reactive) polycythemiasTHIELE, Juergen; KVASNICKA, Hans Michael; ZANKOVICH, Rudolph et al.Haematologica (Roma). 2001, Vol 86, Num 4, pp 368-374, issn 0390-6078Article
Essential thrombocythemia with ringed sideroblasts: a heterogeneous spectrum of diseases, but not a distinct entitySCHMITT-GRAEFF, Annette; THIELE, Juergen; ZUK, Irina et al.Haematologica (Roma). 2002, Vol 87, Num 4, pp 392-399, issn 0390-6078Article
Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosisTHIELE, Juergen; KVASNICKA, Hans Michael; ZANKOVICH, Rudolf et al.Annals of hematology (Print). 2001, Vol 80, Num 3, pp 160-165, issn 0939-5555Article
Clinicopathological criteria for differential diagnosis of thrombocythemias in various myeloproliferative disordersTHIELE, Juergen; KVASNICKA, Hans Michael.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 3, pp 219-230, issn 0094-6176, 12 p.Article
Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemiaCAROBBIO, Alessandra; FINAZZI, Guido; VANNUCCHI, Alessandro M et al.American journal of hematology. 2012, Vol 87, Num 2, pp 203-204, issn 0361-8609, 2 p.Article
Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer : Implications for response classificationSCHNEIDER, Paul M; BALDUS, Stephan E; HOELSCHER, Arnulf H et al.Annals of surgery. 2005, Vol 242, Num 5, pp 684-692, issn 0003-4932, 9 p.Article
Mixed chimerism of the resident macrophage population after allogeneic bone marrow transplantation for chronic myeloid leukemiaWICKENHAUSER, Claudia; THIELE, Juergen; PEREZ, Fernando et al.Transplantation. 2002, Vol 73, Num 1, pp 104-111, issn 0041-1337Article
Bone marrow features improve prognostic efficiency in Multivariate risk classification of chronic-phase Ph1+ chronic myelogenous leukemia: a multicenter trialKVASNICKA, Hans Michael; THIELE, Juergen; SCHMITT-GRAEFF, Annette et al.Journal of clinical oncology. 2001, Vol 19, Num 12, pp 2994-3009, issn 0732-183XArticle
Impact of bone marrow morphology on multivariate risk classification in chronic myelogenous leukemiaKVASNICKA, Hans Michael; THIELE, Juergen; SCHMITT-GRAEFF, Annette et al.Acta haematologica. 2003, Vol 109, Num 1, pp 53-56, issn 0001-5792, 4 p.Article
Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia : a multicentre study on 495 patientsKVASNICKA, Hans Michael; THIELE, Juergen; SCHMITT-GRAEFF, Annette et al.British journal of haematology. 2001, Vol 112, Num 3, pp 727-739, issn 0007-1048Article
Development and validation of an International Prognostic Score of thrombosis in World Health Organization―essential thrombocythemia (IPSET-thrombosis)BARBUI, Tiziano; FINAZZI, Guido; GISSLINGER, Heinz et al.Blood. 2012, Vol 120, Num 26, pp 5128-5133, issn 0006-4971, 6 p.Article
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International StudyBARBUI, Tiziano; THIELE, Juergen; MARINO, Filippo et al.Journal of clinical oncology. 2011, Vol 29, Num 23, pp 3179-3184, issn 0732-183X, 6 p.Article
Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosisHARTMANN, Karin; ARTUC, Metin; BALDUS, Stephan E et al.The American journal of pathology. 2003, Vol 163, Num 3, pp 819-826, issn 0002-9440, 8 p.Article
Mixed chimerism of cardiomyocytes and vessels after allogeneic bone marrow and stem-cell transplantation in comparison with cardiac allograftsTHIELE, Juergen; VARUS, E. V. A; WICKENHAUSER, Claudia et al.Transplantation. 2004, Vol 77, Num 12, pp 1902-1905, issn 0041-1337, 4 p.Article
Follow-up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): A retrospective clinicopathological study of 120 patientsTHIELE, Juergen; KVASNICKA, Hans Michael; SCHMITT-GRAEFF, Annette et al.American journal of hematology. 2002, Vol 70, Num 4, pp 283-291, issn 0361-8609Article
Effects of anagrelide on megakaryopoiesis and platelet productionTHIELE, Juergen; KVASNICKA, Hans Michael; SCHMITT-GRAEFF, Annette et al.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 4, pp 352-361, issn 0094-6176, 10 p.Article
Bone marrow histopathology in myeloproliferative disorders : Current diagnostic approachTHIELE, Juergen; KVASNICKA, Hans Michael; ORAZI, Attilio et al.Seminars in hematology. 2005, Vol 42, Num 4, pp 184-195, issn 0037-1963, 12 p.Article
Anagrelide-induced bone marrow changes during therapy of chronic myeloproliferative disorders with thrombocytosis. An immunohistochemical and morphometric study of sequential trephine biopsiesTHIELE, Juergen; KVASNICKA, Hans Michael; FUCHS, Nina et al.Haematologica (Roma). 2003, Vol 88, Num 10, pp 1130-1138, issn 0390-6078, 9 p.Article
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)TEFFERI, Ayalew; BAROSI, Giovanni; CORTES, Jorge et al.Blood. 2006, Vol 108, Num 5, pp 1497-1503, issn 0006-4971, 7 p.Article